Skip to main content
Premium Trial:

Request an Annual Quote

Eichler Brings Genome Hot Spot Studies to Washington


Evan Eichler was lured to the genome sciences department at the University of Washington by the same factor that originally brought him to Case Western Reserve University in the fall of 1997: its people.

Such names as Hunt Willard and Aravinda Chakravarti served to draw Eichler, a budding genomicist who would become well known through the field as a pioneer in the study of rapidly evolving portions of the genome — particularly duplicated sequence — to Case. In the past few years many of Eichler’s colleagues there have gone on to other institutions, and while Eichler calls Case a “great environment to start out in,” he eventually realized that he was “trying to find that magic again.”

His new post, as a tenured associate professor at Washington, feels that it has that promise, Eichler says. “There’s a lot of depth and breadth to the genome community here,” he says of the department chaired by Bob Waterston and populated with such names as Maynard Olson, Deirdre Meldrum, and Phil Green.

Which is why Eichler packed up in May and drove out West with six of his lab members (three more would follow later). He and his team are diving into studying the structures of genomes to find evolutionary components. “We’re up to our eyeballs in chimp genome sequence, and we’ll be looking at the macaque sequence,” he says.

A key theory he’s studying is the idea that the evolutionary hot spots he’s already identified — places where duplications arise faster or regions are deleted faster than most of the genome — could explain conditions such as mental retardation, which he says hasn’t been understood yet through more traditional linkage disequilibrium studies using SNPs, for example. His lab is working with external groups to collect patient samples and is “also trying to develop computational methods to detect duplications” in genome sequences, Eichler says. His work will also benefit, he predicts, from collaborations with the Fred Hutchinson Cancer Research Center, where Eichler has an adjunct faculty appointment.

In the few months since he took his new position, Eichler says he’s received more postdoc applications than he did in six and a half straight years at Case. “People want to live out West. Cleveland unfortunately wasn’t a beacon on the hill for people to live at,” he says. The level of interest is a great perk, Eichler says, but it won’t change the size of his lab, which he envisions keeping around 12 to 15 people. “That way I can still be involved and not have to have a lot of hierarchy in the group,” he adds.

Beyond his own lab, Eichler’s excited about the dynamics of his new home. The department still has five or six slots to fill, he says, and in about a year and a half the genome sciences team will be moving to a brand new facility along with the bioengineering department. “There’s so much excitement here,” Eichler says. “There’s so much energy.”

— Meredith Salisbury

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.